Alexion Pharmaceuticals, Inc. (ALXN) Tops Q1 EPS by 6c; Ups Guidance
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Financial Fact:
Income before income taxes: 169.97M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income before income taxes: 169.97M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reported Q1 EPS of $0.45, $0.06 better than the analyst estimate of $0.39. Revenue for the quarter came in at $244.7 million versus the consensus estimate of $241.14 million.
Alexion Pharmaceuticals, Inc. sees FY2012 EPS of $1.65-$1.75, versus prior guidance of $1.60-$1.70 and the consensus of $1.74. Alexion Pharmaceuticals, Inc. sees FY2012 revenue of $1.065-$1.085 billion, versus prior guidance of $1.04-$1.07 billion and the consensus of $1.07 billion.
For earnings history and earnings-related data on Alexion Pharmaceuticals, Inc. (ALXN) click here.
Alexion Pharmaceuticals, Inc. sees FY2012 EPS of $1.65-$1.75, versus prior guidance of $1.60-$1.70 and the consensus of $1.74. Alexion Pharmaceuticals, Inc. sees FY2012 revenue of $1.065-$1.085 billion, versus prior guidance of $1.04-$1.07 billion and the consensus of $1.07 billion.
For earnings history and earnings-related data on Alexion Pharmaceuticals, Inc. (ALXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance
- Omega Flex (OFLX) Tops Q2 EPS by 27c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
